DS
MBIO icon

DRW Securities’s Mustang Bio MBIO Stock Holding History

DRW Securities’s Portfolio MBIO Stock Details MBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-73,936
Closed -$72.5K – 1563
2025
Q4 		$72.5K Buy
+73,936
New +$97.6K ﹤0.01% 1093

Other funds holding MBIO

KAS
Kestra Advisory Services Austin, Texas $26.4B AUM 21.05% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
CG
CFO4Life Group Coppell, Texas $656M AUM 17.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

DRW Securities's MBIO Position: Q1 2026 in Review

DRW Securities sold out of Mustang Bio (MBIO) in Q1 2026, closing a stake of 73,936 shares — an estimated $72.5K sold.

DRW Securities first reported a position in MBIO in Q4 2025 and held it in 1 quarter. The position peaked at $72.5K in Q4 2025. 22 funds tracked by Wall St. Rank hold MBIO as of Q1 2026.

  • DRW Securities reported no remaining Mustang Bio position as of Q1 2026 after selling out during the quarter.
  • DRW Securities sold 73,936 Mustang Bio shares in Q1 2026, an estimated $72.5K.
  • DRW Securities first reported a position in Mustang Bio in Q4 2025 and held it in 1 quarter.
  • DRW Securities's Mustang Bio position peaked at $72.5K in Q4 2025.
  • 22 funds tracked by Wall St. Rank held Mustang Bio as of Q1 2026.

Based on DRW Securities's 13F filing for Q1 2026, filed 13 May 2026.